Japan's Kyowa Hakko Kirin Aims For Top Five Of Antibody Makers
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin of Japan and its President Yuzuru Matsuda have set a goal of moving into the top five global developers of antibodies, beginning with treatments for cancer